The FDA approved VIZZ, the first aceclidine-based eye drops for presbyopia. The drops create a controlled “pinhole effect,” improving near vision without blurring distance vision. Expected late 2025 availability for the ~128M Americans with age-related near-vision loss.
Bottom line: daily drops could replace readers for many users.
Read more → WebMD